Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Risk of endometrial cancer following estrogen replacement with and without progestins.
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation.
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I.
Hormone replacement and breast cancer. A remaining controversy?
More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
The risk of breast cancer after estrogen and estrogen-progestin replacement.
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.
Long-term consequences of estrogen and estrogen-progestin replacement.
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
Menopausal hormone therapy and cancer risk: An overestimated risk?
Different menopausal hormone regimens and risk of breast cancer.